- Home
- ESNT vs BPMC Comparison
ESNT vs BPMC Comparison
Compare ESNT & BPMC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESNT
- BPMC
- Stock Information
- Founded
- ESNT 2008
- BPMC 2008
- Country
- ESNT Bermuda
- BPMC United States
- Employees
- ESNT N/A
- BPMC N/A
- Industry
- ESNT Property-Casualty Insurers
- BPMC Biotechnology: Pharmaceutical Preparations
- Sector
- ESNT Finance
- BPMC Health Care
- Exchange
- ESNT Nasdaq
- BPMC Nasdaq
- Market Cap
- ESNT 5.9B
- BPMC 5.9B
- IPO Year
- ESNT 2013
- BPMC 2015
- Fundamental
- Price
- ESNT $53.32
- BPMC $90.14
- Analyst Decision
- ESNT Buy
- BPMC Buy
- Analyst Count
- ESNT 7
- BPMC 20
- Target Price
- ESNT $64.71
- BPMC $120.79
- AVG Volume (30 Days)
- ESNT 756.3K
- BPMC 667.8K
- Earning Date
- ESNT 02-07-2025
- BPMC 02-13-2025
- Dividend Yield
- ESNT 2.10%
- BPMC N/A
- EPS Growth
- ESNT 10.79
- BPMC N/A
- EPS
- ESNT 6.90
- BPMC N/A
- Revenue
- ESNT $1,184,351,000.00
- BPMC $434,415,000.00
- Revenue This Year
- ESNT N/A
- BPMC $108.09
- Revenue Next Year
- ESNT $4.81
- BPMC $39.34
- P/E Ratio
- ESNT $7.72
- BPMC N/A
- Revenue Growth
- ESNT 15.06
- BPMC 100.93
- 52 Week Low
- ESNT $50.66
- BPMC $72.24
- 52 Week High
- ESNT $65.33
- BPMC $121.90
- Technical
- Relative Strength Index (RSI)
- ESNT 34.02
- BPMC 42.11
- Support Level
- ESNT $52.22
- BPMC $86.02
- Resistance Level
- ESNT $55.95
- BPMC $98.41
- Average True Range (ATR)
- ESNT 1.10
- BPMC 3.28
- MACD
- ESNT -0.20
- BPMC -0.76
- Stochastic Oscillator
- ESNT 21.53
- BPMC 33.04
About ESNT Essent Group Ltd.
Essent Group Ltd serves the housing finance industry by providing private mortgage insurance, reinsurance, risk management products and title insurance and settlement services to mortgage lenders, borrowers, and investors to support homeownership. It provides credit protection to lenders and mortgage investors by covering a portion of the unpaid principal balance of a mortgage and certain related expenses in the event of a default. By providing capital to mitigate mortgage credit risk, the company allows lenders to make additional mortgage financing available to prospective homeowners. Essent writes mortgage guaranty coverage in all 50 states and the District of Columbia.
About BPMC Blueprint Medicines Corporation
Blueprint Medicines Corp is a biopharmaceutical company. It is focused on improving the lives of patients with diseases driven by abnormal kinase activation. The company has developed a small molecule drug pipeline in cancer and a rare genetic disease. Its drug candidates includes AYVAKIT for the treatment of systemic mastocytosis, BLU-808 a potential treatment for mast cell disorders, including chronic urticaria, sleep disruption and other related diseases. It also has other drugs in its pipeline such as BLU-956, BLU-222 for treatment of breast cancer.